Qube Research & Technologies Ltd - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 138 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$2,838,674
+745.9%
127,010
+713.3%
0.01%
+600.0%
Q2 2023$335,588
-60.0%
15,616
-55.3%
0.00%
-75.0%
Q1 2023$838,786
+109.2%
34,964
+77.5%
0.00%
+33.3%
Q1 2022$401,000
-73.8%
19,699
-75.9%
0.00%
-75.0%
Q4 2021$1,529,000
+194.6%
81,876
+211.4%
0.01%
+71.4%
Q3 2021$519,000
+21.8%
26,295
+46.0%
0.01%
+40.0%
Q2 2021$426,000
-9.6%
18,015
-9.3%
0.01%
-28.6%
Q1 2021$471,000
-5.8%
19,859
-20.4%
0.01%0.0%
Q4 2020$500,000
+23.2%
24,955
+26.6%
0.01%
-46.2%
Q4 2019$406,00019,7080.01%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q4 2020
NameSharesValueWeighting ↓
Tejara Capital Ltd 289,803$6,477,0973.67%
Tamarack Advisers, LP 185,000$4,134,7502.68%
Rubric Capital Management LP 3,175,000$70,961,2502.66%
Eventide Asset Management 2,631,334$58,810,3151.06%
Camber Capital Management LP 1,050,000$23,4680.77%
EMERALD MUTUAL FUND ADVISERS TRUST 559,480$12,504,3780.76%
EMERALD ADVISERS, LLC 690,487$15,432,3800.75%
Values First Advisors, Inc. 43,507$972,3740.63%
AlphaCentric Advisors LLC 49,500$1,106,3250.63%
SummerHaven Investment Management, LLC 33,666$752,4350.55%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders